ClinicalTrials.Veeva

Menu

How do Alpha Oscillations Shape the Perception of Pain? - An EEG-based Neurofeedback Study

T

Technical University of Munich

Status

Completed

Conditions

Experimental Pain in Healthy Human Subjects

Treatments

Behavioral: attention left training, ALTNF
Behavioral: sham attention left training, ALTsham
Behavioral: sham attention right training, ARTsham
Behavioral: attention right training, ARTNF

Study type

Interventional

Funder types

Other

Identifiers

NCT05570695
09/2022

Details and patient eligibility

About

Pain is closely linked to alpha oscillations (8 -13 Hz) which are thought to represent a supra-modal, top-down mediated gating mechanism that shapes sensory processing. Consequently, alpha oscillations might also shape the cerebral processing of nociceptive input and eventually the perception of pain. To test this mechanistic hypothesis, the investigators designed a sham-controlled and double-blind electroencephalography (EEG)-based neurofeedback study. In a short-term neurofeedback training protocol, healthy participants will learn to up- and downregulate somatosensory alpha oscillations using attention. Subsequently, the investigators will investigate how this manipulation impacts experimental pain applied during neurofeedback. Using Bayesian statistics and mediation analysis, the investigators will test whether alpha oscillations mediate attention effects on pain perception. This approach promises causal insights into the role of alpha oscillations in shaping pain, and thereby extends previous correlative evidence. Beyond, it can aid the development of novel, non-invasive modulatory treatment approaches for chronic pain, which are urgently needed.

The prosed study protocol has been granted in-principle acceptance from PLOS Biology and the corresponding registration can be found at the OSF online repository [www.osf.io/qbkj2].

Enrollment

75 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • aged 18-45 years
  • right-handedness (laterality quotient > 60 on the Edinburgh handedness inventory)
  • good command of German
  • written informed consent
  • attendance at both sessions and compliance with instructions throughout the experiment

Exclusion criteria

  • pregnancy
  • neurological or psychiatric diseases (e.g., epilepsy, stroke, depression, anxiety disorders)
  • severe general illnesses (e.g., tumors, diabetes)
  • skin diseases (e.g., dermatitis, psoriasis or eczema)
  • current or recurrent pain
  • regular intake of medication (aside from contraception, thyroidal, and antiallergic medication)
  • surgical procedures involving the head or spinal cord
  • side-effects following previous thermal stimulation
  • contact to a person with a SARS-CoV-2 infection within the last 2 weeks
  • current symptoms of a cold or flu

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

neurofeedback
Experimental group
Description:
Modulation of brain activity using verum and sham neurofeedback.
Treatment:
Behavioral: sham attention left training, ALTsham
Behavioral: sham attention right training, ARTsham
Behavioral: attention right training, ARTNF
Behavioral: attention left training, ALTNF

Trial contacts and locations

1

Loading...

Central trial contact

Markus Ploner, Prof. Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems